Research Article Open Access

Polymyositis Initiation Involving Amlodipine Besylate

R. M. Golding1, L. G.F. Giles2 and E. M. Sokoya3
  • 1 The University of New South Wales, Australia
  • 2 University of North Queensland, Australia
  • 3 Baylor College of Medicine, United States

Abstract

Based on extensive blood pressure data and results from a scientific model of the analysis of the rate processes involved in polymyositis the evidence suggests that the polymyositis in a particular patient was initiated by taking the drug amlodipine besylate (norvasc). The method of our analysis should serve as a foundation in handling other drug related interactions.

American Journal of Immunology
Volume 2 No. 1, 2006, 19-22

DOI: https://doi.org/10.3844/ajisp.2006.19.22

Submitted On: 1 March 2006 Published On: 31 March 2006

How to Cite: Golding, R. M., Giles, L. G. & Sokoya, E. M. (2006). Polymyositis Initiation Involving Amlodipine Besylate. American Journal of Immunology, 2(1), 19-22. https://doi.org/10.3844/ajisp.2006.19.22

  • 3,082 Views
  • 2,541 Downloads
  • 0 Citations

Download

Keywords

  • Polymyositis
  • blood pressure
  • amlodipine besylate (norvasc)
  • steroid therapy